Eb5 Age Spot Treatment Cream Recalled for Stability Failures
Eb5 Corporation is recalling 4,632 tubes of Age Spot Treatment Cream because the product failed stability specifications for viscosity, pH, and specific gravity.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves failed stability specifications (viscosity, pH, specific gravity) without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Eb5 Corporation is voluntarily recalling 4,632 tubes of eb5 Skincare that Works. Age Spot Treatment. Skin Lightening Cream with 2% Hydroquinone. The product is packaged in a 177.4 ml / 6 fl oz carton containing a tube. The recall is limited to Batch B4276A with an expiration date of 03/2019.
The recall was initiated because the product failed stability specifications, specifically testing out-of-specification for viscosity, pH, and specific gravity. The product was distributed nationwide in the USA.
Consumers who have this specific batch of the product should stop using it and contact Eb5 Corporation for further instructions or a refund.
The recalled product
- Product
- eb5 Skincare that Works. Age Spot Treatment. Skin Lightening Cream with 2% Hydroquinone. 177.4 ml / 6 fl oz carton containing a tube. Manufactured For: EB5 Corporation Portland, OR 97210 Carton Bar Code: 7 41099 00009 9
- Manufacturer
- Eb5 Corporation
- Category
- Drug — Topical Skin Lightening
- Affected units
- 4,632
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch B4276A EXP 03/2019
Distribution
Distribution scope not specified by the agency.
Related recalls
Same hazard · stability failure
See all →- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
Similar recalls
- ModerateProduct Quest Recalls Dr. Brandt BB Cream for Stability Failures
FDA (Drugs) · 2018-10-24
- LowEstee Lauder DayWear Moisturizer Recalled for Potential Sunscreen Instability
FDA (Drugs) · 2013-02-13
- LowVi-Jon Recalls Equate and Studio 35 Face Moisturizers for Stability Failures
FDA (Drugs) · 2017-11-01
- ModerateLidocaine-Prilocaine Cream Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- ModerateOdan Laboratories Recalls Day Cream SPF15 Due to Stability Failure
FDA (Drugs) · 2018-01-31
- ModerateAkorn Recalls Clobetasol Propionate Cream Due to Preservative Stability Failure
FDA (Drugs) · 2019-02-27